Nektar Therapeutics NKTR
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 71.95 | 111.11 | -1.82 | -39,054 | -45 | |
| 2025Q4 | 42.28 | 110.96 | -1.59 | -27,665 | -36 | |
| 2025Q3 | 56.9 | 109.31 | 1.87 | -31,672 | -36 | |
| 2025Q2 | 25.84 | 106.56 | -2.95 | -36,230 | -42 | |
| 2025Q1 | 10.2 | 107.59 | -3.62 | -44,535 | -51 | |
| 2024Q4 | 13.95 | 24.93 | 0.59 | 14,348 | 7 | |
| 2024Q3 | 19.5 | 110.69 | -2.7 | -34,345 | -37 | |
| 2024Q2 | 18.6 | 108.42 | -3.75 | -49,774 | -52 | |
| 2024Q1 | 14.01 | 113.16 | -2.85 | -35,427 | -37 | |
| 2023Q4 | 8.48 | 95.09 | -3.3 | -33,511 | -42 | |
| 2023Q3 | 8.93 | 112.19 | -3.6 | -44,864 | -46 | |
| 2023Q2 | 8.63 | 112.4 | -3.9 | -50,599 | -51 | |
| 2023Q1 | 10.54 | 103.09 | -10.95 | -134,710 | -137 | |
| 2022Q4 | 33.9 | 106.34 | -4.8 | -52,469 | -60 | |
| 2022Q3 | 48 | 103.92 | -4.65 | -54,301 | -59 | |
| 2022Q2 | 57 | 100.72 | -12.75 | -152,836 | -159 | |
| 2022Q1 | 80.85 | 140.88 | -7.35 | -116,560 | -90 | |
| 2021Q4 | 202.65 | 82.1 | -11.85 | -112,910 | -146 | |
| 2021Q3 | 269.4 | 97.26 | -10.5 | -113,596 | -130 | |
| 2021Q2 | 257.4 | 98.33 | -10.35 | -110,205 | -126 |